During the past decade, Aravind Eye Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aravind Eye Hospital" #1 sponsor was "Aurolab" with 14 trials, followed by "University of California, San Francisco" with 10 trials sponsored, "Aravind Eye Care System" with 2 trials sponsored, "National Eye Institute (NEI)" with 2 trials sponsored and "Thomas M. Lietman" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aravind Eye Hospital" #1 collaborator was "Aravind Eye Hospitals, India" with 9 trials as a collaborator, "National Eye Institute (NEI)" with 7 trials as a collaborator, "Aravind Eye Care System" with 5 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 4 trials as a collaborator and "Stanford University" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Aravind Eye Hospital" are "Cataract" (7 trials), "Corneal Ulcer" (5 trials), "Glaucoma" (5 trials), "Uveitis" (3 trials) and "Acanthamoeba Keratitis" (2 trials). Many other conditions were trialed in "Aravind Eye Hospital" in a lesser frequency.

Most popular intervention types in "Aravind Eye Hospital" are "Drug" (16 trials), "Device" (9 trials), "Other" (8 trials), "Procedure" (7 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Voriconazole" (3 trials), "Methotrexate" (2 trials), "Moxifloxacin Ophthalmic" (2 trials) and "Mycophenolate mofetil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aravind Eye Hospital" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Aravind Eye Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Aravind Eye Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Aravind Eye Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 8 trials that are defined as “Not Applicable".